Welcome, Guest. Please login or register.
November 17, 2019, 05:07:51 pm

Login with username, password and session length

  • Total Posts: 749266
  • Total Topics: 62902
  • Online Today: 257
  • Online Ever: 4912
  • (November 13, 2019, 02:56:14 am)
Users Online
Users: 1
Guests: 221
Total: 222


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: 'Can opener' molecule makes HIV vulnerable to attack  (Read 1846 times)

0 Members and 1 Guest are viewing this topic.

Offline Almost2late

  • Member
  • Posts: 1,147
'Can opener' molecule makes HIV vulnerable to attack
« on: May 06, 2015, 08:05:45 pm »
Not sure if this is new but it doesn't sound familiar " JP-III-48".. so much research it makes me dizzy.. But I can't get enough of it..

"A molecule that mimics a particular kind of protein has been demonstrated by a new study to render HIV vulnerable to antibodies that could kill off infected cells.
HIV in the bloodstream.
The JP-III-48 molecule forces HIV to open up and expose regions that are vulnerable to attack from the immune system.

Researchers from the Centre hospitalier de l'Université de Montréal (CHUM) Research Centre in Canada have described the molecule in question, JP-III-48, as acting like a "can opener" due to the way that it forces the human immunodeficiency virus (HIV) to open up and expose its vulnerable parts.

Study author Andrés Finzi, a professor at the University of Montreal, states the team also found that people infected with HIV-1 virus have naturally occurring antibodies with the potential to kill infected cells.

"We just have to give them a little push by adding a tiny molecule that acts as a can opener to force the viral envelope to expose regions recognized by the antibodies, which forms a bridge with some cells of the immune system, initiating the attack," Prof. Finzi explains.

The development of a vaccine to prevent HIV infection has long been a goal of researchers. At present, antiretroviral drugs are used to slow the virus down but they are unable to prevent the formation of HIV "reservoirs" - areas where the virus remains hidden and dormant within cells. As soon as antiretroviral treatment ends, the virus returns.

Worldwide, around 35 million people are estimated to be infected with HIV-1, the predominant form of the virus. It is hoped that this new discovery could lead toward the development of a vaccine to finally stop the spread of HIV.
'Shock and kill' therapy may be the key to future HIV treatment

Previous research published earlier this year demonstrated that cells infected with HIV-1 were more easily eliminated when two HIV-specific proteins, Nef and Vpu, were deactivated by gene mutation.

This finding formed the basis of the new study, published in Proceedings of the National Academy of Sciences. These two proteins protect the virus from attack. If these proteins could be overcome, the virus becomes vulnerable.

The researchers added the JP-III-48 molecule to the surfaces of cells infected with HIV. This molecule imitates a protein called CD4 which is often found on the surface of white blood cells called T lymphocytes. CD4 proteins make these white blood cells vulnerable to HIV infection.

Jonathan Richard, a postdoctoral researcher at CHUM and study author, explains how the introduction of JP-III-48 subsequently makes infected cells vulnerable to attack:

    "The virus has to get rid of the CD4 proteins to protect itself. Adding the small molecule forces the viral envelope to open, like a flower. The antibodies that are naturally present after the infection can then target the infected cells so they are killed by the immune system."

JP-III-48 was previously developed by researchers from Harvard University and the University of Pennsylvania. This study marks the first time the molecule has been tested successfully on patients with HIV.

Prof. Finzi believes that the molecule could be used as part of a treatment to eliminate the HIV reservoirs of people infected with the virus. "The solution is to develop a 'shock and kill' therapy," he states. "We have to reactivate HIV reservoirs to force the virus out of its hiding place, then kill the infected cells with this molecule and the already present antibodies."

The molecule could also be potentially used as a component in a two-part vaccine, alongside antibodies to target the virus. The next step for the team is to assess JP-III-48 capabilities in tests involving monkeys.

Recently, Medical News Today reported on the creation of a new drug candidate against HIV. The researchers state that the designer protein is effective against all known strains of HIV."

"Hang on to your hopes my friend..
thats an easy thing to say,
but if your hope should pass away,
simply pretend that you could build them again"...

Offline tryingtostay

  • Member
  • Posts: 588
Re: 'Can opener' molecule makes HIV vulnerable to attack
« Reply #1 on: May 08, 2015, 06:11:36 pm »
Don't make me open up a can of whoop ass on you HIV!


Terms of Membership for these forums

© 2019 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.